tiprankstipranks
New Horizon Health Limited (HK:6606)
HKEX:6606
Hong Kong Market

New Horizon Health Limited (6606) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

6606 Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
New
Horizon Health Limited
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

6606 Stock 12 Month Forecast

There Are No Analyst Ratings for HK:6606 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

6606 Financial Forecast

6606 Earnings Forecast

Next quarter’s earnings estimate for 6606 is HK$0.45 with a range of HK$0.45 to HK$0.45. The previous quarter’s EPS was HK$0.27. 6606 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 41.32% of the time in the same period. In the last calendar year 6606 has Underperformed its overall industry.
Next quarter’s earnings estimate for 6606 is HK$0.45 with a range of HK$0.45 to HK$0.45. The previous quarter’s EPS was HK$0.27. 6606 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 41.32% of the time in the same period. In the last calendar year 6606 has Underperformed its overall industry.

6606 Sales Forecast

Next quarter’s sales forecast for 6606 is HK$1.56B with a range of HK$1.56B to HK$1.56B. The previous quarter’s sales results were ―. 6606 beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 55.77% of the time in the same period. In the last calendar year 6606 has Outperformed its overall industry.
Next quarter’s sales forecast for 6606 is HK$1.56B with a range of HK$1.56B to HK$1.56B. The previous quarter’s sales results were ―. 6606 beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 55.77% of the time in the same period. In the last calendar year 6606 has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Analyst Performance
Any
Any
Analyst Rating
Any
Any
Upside / Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs
HK$52.5HK$49
Buy
HK$49.00
(246.53% Upside)
Reiterated
09/07/23
New Horizon Health Ltd (6606:HK) PT Lowered to HK$49 at Goldman SachsGoldman Sachs analyst Ziyi Chen lowered the price target on New Horizon Health Ltd (6606:HK) to HK$49.00 (from HK$52.50) while maintaining a Conviction Buy rating.
UBS Analyst forecast on HK:6606
Unknown Analyst
Not Ranked
UBS
HK$29
Buy
HK$29.00
(105.09% Upside)
Reiterated
03/29/24
UBS Reiterates Buy Rating on New Horizon Health Ltd (6606:HK)UBS analyst Vincy IP reiterated a Buy rating and HK$29.00 price target on New Horizon Health Ltd (6606:HK).

Best Analysts Covering New Horizon Health Limited

Which Analyst Should I Follow If I Want to Buy HK:6606 and Sell After:
1 Month
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+1.20%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +1.20% per trade.
3 Months
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+21.80%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +21.80% per trade.
1 Year
Ziyi ChenGoldman Sachs
Success Rate
0/1 ratings generated profit
0%
Average Return
-25.50%
reiterated a buy rating 11 months ago
Copying Ziyi Chen's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -25.50% per trade.
2 Years
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-25.50%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -25.50% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

6606 Analyst Recommendation Trends

Rating
Jun 23
Jul 23
Sep 23
Mar 24
May 24
Strong Buy
0
3
4
5
2
Buy
1
1
1
0
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
4
5
5
3
In the current month, 6606 has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 6606 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

6606 Stock Forecast FAQ

What is HK:6606’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:6606’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:6606, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is New Horizon Health Limited a Buy, Sell or Hold?
      Currently, no data Available
      What is New Horizon Health Limited’s share price target?
      Currently, no data Available
      What do analysts say about New Horizon Health Limited?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of New Horizon Health Limited?
      To buy shares of HK:6606, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis